Zenas BioPharma, INC. and U.S. Bank Trust Company, National Association as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of March 31, 2026 2.50% Convertible Senior Notes due 2032 CROSS REFERENCE TABLE*